Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2009 Results on February 11, 2010
Thursday, Jan 28, 2010
Alexion to Present at the 28th Annual JP Morgan Healthcare Conference
Wednesday, Jan 6, 2010
Soliris(R) Reduced Hemolysis, Lowered Thrombosis Rate and Improved Quality of Life in Patients with PNH Who Had Previously Never Been Transfused
Monday, Dec 7, 2009
Soliris® Reversed Thrombocytopenia in Patients with Both PNH and Pre-Existing Thrombocytopenia in Study Presented at ASH Annual Meeting
Monday, Dec 7, 2009
Soliris(R) Reduced Hemolysis, Decreased Transfusion Requirements and Improved Fatigue in Patients with PNH and Bone Marrow Insufficiency Disorders
Sunday, Dec 6, 2009
Researchers Report Clinical Association Between Type II PNH Cells and Thrombocytopenia
Sunday, Dec 6, 2009
Long-Term Soliris(R) Treatment Resulted in Sustained Reduction in Hemolysis and Improved Kidney Function in Japanese Patients with PNH
Saturday, Dec 5, 2009
Alexion Reports Progress on Commissioning of Rhode Island Manufacturing Facility as Second Source of Supply
Wednesday, Dec 2, 2009
Alexion Appoints William R. Keller to its Board of Directors
Tuesday, Dec 1, 2009
Alexion to Present at Lazard Capital Markets 6th Annual Healthcare Conference
Wednesday, Nov 11, 2009
Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of Patients With PNH at the ASH Annual Meeting
Tuesday, Nov 10, 2009
Alexion to Present at Credit Suisse's 2009 Healthcare Conference
Thursday, Nov 5, 2009
Alexion to Present at the Oppenheimer 20th Annual Healthcare Conference
Wednesday, Oct 28, 2009
Alexion Reports Third Quarter 2009 Results
Thursday, Oct 22, 2009
Alexion Pharmaceuticals to Report Third Quarter 2009 Results on October 22, 2009
Monday, Oct 12, 2009
Alexion to Present at the UBS Global Life Sciences Conference
Wednesday, Sep 16, 2009
Alexion to Present at Investor Conferences
Tuesday, Sep 8, 2009
European Commission and U.S. FDA Grant Alexion's Soliris® (eculizumab) Orphan Drug Designation for the Treatment of Atypical Hemolytic Uremic Syndrome (aHUS)
Thursday, Aug 6, 2009
Alexion Reports Second Quarter 2009 Results
Thursday, Jul 23, 2009
Alexion Pharmaceuticals to Report Second Quarter 2009 Results on July 23, 2009
Thursday, Jul 9, 2009
Showing 1-20 of 136 releases Page: 1 2 3 4 5 6 7  See Next 20